Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Breast Cancer
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Provided treatments

  • Drug: Fulvestrant
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02909361. The sponsor of the trial is Fudan University and it is looking for 500 volunteers for the current phase.
Official trial title:
A Multicenter, Prospective, Real-world Study to Evaluate the Safety Profile and Effectiveness in Chinese Patients Who Received Fulvestrant 500mg as First-line Endocrine Treatment for Advanced Breast Cancer